Investment
Features
FeesSafety
Academy
More
Pluang+

Litecoin hits 15 years as Grayscale seeks to list its trust as an ETF on NYSE Arca

Market News
07 Oct 2026
Tokenpost
View Source
Bullish
Litecoin hits 15 years as Grayscale seeks to list its trust as an ETF on NYSE Arca

Litecoin celebrated 15 years since its creation, designed as a faster alternative to Bitcoin with a 2.5-minute block time and a max supply of 84 million LTC. Grayscale is pursuing plans to convert its Litecoin Trust, currently trading over the counter, into an exchange-traded fund (ETF) listed on NYSE Arca. This move would allow U.S. investors to access Litecoin exposure through a conventional stock exchange rather than an OTC trust. The conversion depends on regulatory approval and represents a significant step in making Litecoin more accessible to mainstream investors.

Litecoin's 15th anniversary and Grayscale's NYSE Arca listing plans provide context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Oct 07, 2026 21:23 WIB: out of 50 major cryptocurrencies, 5 rose and 43 fell. Notable movers include SXP at Rp37 with a 1-day change of -46.27%, ENJ at Rp523 down 11.93%, and EGLD at Rp71,582 down 11.73%.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
59 minutes ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
1 hour ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App